OBJECTIVE: Scientific and clinical interest in attention-deficit hyperactivity disorder (ADHD) is increasing worldwide. This article presents data from a cross-national workshop and survey related to questions of variability in diagnostic and, particularly, treatment procedures. METHODS: Representatives of nine nations (Australia, Brazil, Canada, China, Germany, Israel, the Netherlands, Norway, and the United Kingdom), plus the United States, who attended a 2010 workshop on ADHD, responded to a survey that addressed diagnostic procedures for ADHD; treated prevalence of medication approaches, as well as psychosocial interventions; types of medications and psychosocial treatments in use; payment systems; beliefs and values of the education system; trends related to adult ADHD; and cultural and historical attitudes and influences related to treatment. RESULTS: Use of both medication and psychosocial treatment for ADHD varies widely within and across nations. More expensive long-acting formulations of medications are becoming more widespread. Nations with socialized medical care provide a wide array of evidence-based interventions. Economic, historical, and political forces and cultural values are related to predominant attitudes and practices. Strong antipsychiatry and antimedication voices remain influential in many nations. CONCLUSIONS: There is considerable variation in implementation of care for ADHD. Recognition of the social context of ADHD is an important step in ensuring access to evidence-based interventions for this prevalent, chronic, and impairing condition.
OBJECTIVE: Scientific and clinical interest in attention-deficit hyperactivity disorder (ADHD) is increasing worldwide. This article presents data from a cross-national workshop and survey related to questions of variability in diagnostic and, particularly, treatment procedures. METHODS: Representatives of nine nations (Australia, Brazil, Canada, China, Germany, Israel, the Netherlands, Norway, and the United Kingdom), plus the United States, who attended a 2010 workshop on ADHD, responded to a survey that addressed diagnostic procedures for ADHD; treated prevalence of medication approaches, as well as psychosocial interventions; types of medications and psychosocial treatments in use; payment systems; beliefs and values of the education system; trends related to adult ADHD; and cultural and historical attitudes and influences related to treatment. RESULTS: Use of both medication and psychosocial treatment for ADHD varies widely within and across nations. More expensive long-acting formulations of medications are becoming more widespread. Nations with socialized medical care provide a wide array of evidence-based interventions. Economic, historical, and political forces and cultural values are related to predominant attitudes and practices. Strong antipsychiatry and antimedication voices remain influential in many nations. CONCLUSIONS: There is considerable variation in implementation of care for ADHD. Recognition of the social context of ADHD is an important step in ensuring access to evidence-based interventions for this prevalent, chronic, and impairing condition.
Authors: Sven Bölte; Soheil Mahdi; David Coghill; Susan Shur-Fen Gau; Mats Granlund; Martin Holtmann; Sunil Karande; Florence Levy; Luis A Rohde; Wolfgang Segerer; Petrus J de Vries; Melissa Selb Journal: Eur Child Adolesc Psychiatry Date: 2018-02-12 Impact factor: 4.785
Authors: Robert E McKeown; Joseph R Holbrook; Melissa L Danielson; Steven P Cuffe; Mark L Wolraich; Susanna N Visser Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-11-11 Impact factor: 8.829
Authors: Soheil Mahdi; Nadia Ronzano; Ane Knüppel; José Carlos Dias; Ayman Albdah; Lin Chien-Ho; Omar Almodayfer; Annet Bluschke; Sunil Karande; Huei-Lin Huang; Hanna Christiansen; Mats Granlund; Petrus J de Vries; David Coghill; Rosemary Tannock; Luis Rohde; Sven Bölte Journal: Eur Child Adolesc Psychiatry Date: 2018-02-17 Impact factor: 4.785